Transmission potential of antimony-resistant leishmania field isolates
Jazyk angličtina Země Spojené státy americké Médium print-electronic
Typ dokumentu časopisecké články, práce podpořená grantem
PubMed
25049256
PubMed Central
PMC4187949
DOI
10.1128/aac.02406-13
PII: AAC.02406-13
Knihovny.cz E-zdroje
- MeSH
- antimon farmakologie MeSH
- hmyz - vektory MeSH
- Leishmania infantum patogenita MeSH
- Leishmania patogenita MeSH
- Phlebotomus parazitologie MeSH
- Psychodidae parazitologie MeSH
- zvířata MeSH
- Check Tag
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- Názvy látek
- antimon MeSH
We studied the development of antimony-resistant Leishmania infantum in natural vectors Lutzomyia longipalpis and Phlebotomus perniciosus to ascertain the risk of parasite transmission by sand flies. All three resistant strains produced fully mature late-stage infections in sand flies; moreover, the resistant phenotype was maintained after the passage through the vector. These results highlight the risk of circulation of resistant Leishmania strains and question the use of human drugs for treatment of dogs as Leishmania reservoirs.
Centre de Recherche en Infectiologie du CHUL Québec Québec Canada
Department of Parasitology Faculty of Science Charles University Prague Prague Czech Republic
Ecole Nationale Supérieure Vétérinaire d'Alger Hassan Badi El Harrach Alger Algeria
Zobrazit více v PubMed
Vanlerberghe V, Diap G, Guerin JP, Meheus F, Gerstl S, Van der Stuyft P, Boelaert M. 2007. Drug policy for visceral leishmaniasis: a cost-effectiveness analysis. Trop. Med. Int. Health 12:274–283. 10.1111/j.1365-3156.2006.01782.x PubMed DOI
Abdo MG, Elamin WM, Khalil EAG, Mukhtar MM. 2003. Antimony-resistant Leishmania donovani in eastern Sudan: incidence and in vitro correlation. East Mediterr. Health J. 9:837–843 PubMed
Hadighi R, Mohebali M, Boucher P, Hajjaran H, Khamesipour A, Ouellette M. 2006. Unresponsiveness to glucantime treatment in Iranian cutaneous leishmaniasis due to drug-resistant Leishmania tropica parasites. PLoS Med. 3:e162. 10.1371/journal.pmed.0030162 PubMed DOI PMC
Mittal MK, Rai S, Ashutosh Ravinder Gupta S, Sundar S, Goyal NN. 2007. Characterization of natural antimony resistance in Leishmania donovani isolates. Am. J. Trop. Med. Hyg. 76:681–688 PubMed
Rojas R, Valderrama L, Valderrama M, Varona MX, Ouellette M, Saravia NG. 2006. Resistance to antimony and treatment failure in human Leishmania (Viannia) infection. J. Infect. Dis. 193:1375–1383. 10.1086/503371 PubMed DOI
Sereno D, Maia C, Aït-Oudhia K. 2012. Leishmania antimony resistance and environment: elusive links to explore. Int. J. Parasitol. 2:200–203. 10.1016/j.ijpddr.2012.07.003 PubMed DOI PMC
Aït-Oudhia K, Gazanion E, Vergnes B, Oury B, Sereno D. 2011. Leishmania antimony resistance: what we know what we can learn from the field. Parasitol. Res. 109:1225–1232. 10.1007/s00436-011-2555-5 PubMed DOI
Perry MR, Wyllie S, Raab A, Feldmann J, Fairlamb AH. 2013. Chronic exposure to arsenic in drinking water can lead to resistance to antimonial drugs in a mouse model of visceral leishmaniasis. Proc. Natl. Acad. Sci. U. S. A. 110:19932–19937. 10.1073/pnas.1311535110 PubMed DOI PMC
Adaui V, Maes I, Huyse T, Van der Broeck F, Talledo M, Kuhls K, De Doncker S, Maes L, Llanos-Cuentas A, Schönian G, Arevalo J, Dujardin JC. 2011. Multilocus genotyping reveals a polyphyletic pattern among naturally antimony-resistant Leishmania braziliensis isolates from Peru. Infect. Genet. Evol. 11:1873–1880. 10.1016/j.meegid.2011.08.008 PubMed DOI
Singh S, Kumar DV, Ramesh Negi NS, Singh S, Salotra P. 2006. Visceral leishmaniasis, or kala azar (KA): high incidence of refractoriness to antimony is contributed by anthroponotic transmission via post-KA dermal leishmaniasis. J. Infect. Dis. 194:302–306. 10.1086/505079 PubMed DOI
Aït-Oudhia K, Gazanion E, Sereno D, Oury B, Dedet JP, Pratlong F, Lachaud L. 2012. In vitro susceptibility to antimonials and amphotericin B of Leishmania infantum strains isolated from dogs in a region lacking drug selection pressure. Vet. Parasitol. 187:386–393. 10.1016/j.vetpar.2012.01.034 PubMed DOI
Sereno D, Guilvard E, Maquaire S, Cavaleyra M, Holzmuller P, Ouaissi A, Lemesre JL. 2001. Experimental studies on the evolution of antimony-resistant phenotype during the in vitro life cycle of Leishmania infantum: implications for the spread of chemoresistance in endemic areas. Acta Trop. 80:195–205. 10.1016/S0001-706X(01)00154-1 PubMed DOI
Agnew P, Holzmuller P, Michalakis Y, Sereno D, Lemesre JL, Renaud F. 2001. In vitro growth of Leishmania amazonensis promastigotes resistant to pentamidine is dependent on interactions among strains. Antimicrob. Agents Chemother. 45:1928–1929. 10.1128/AAC.45.6.1928-1929.2001 PubMed DOI PMC
Ouakad M, Vanaerschot M, Rijal S, Sundar S, Speybroeck N, Kestens L, Boel L, De Doncker S, Maes I, Decuypere S, Dujardin JC. 2011. Increased metacyclogenesis of antimony-resistant Leishmania donovani clinical lines. Parasitology 138:1392–1399. 10.1017/S0031182011001120 PubMed DOI
Cihakova J, Volf P. 1997. Development of different Leishmania major strains in the vector sandflies Phlebotomus papatasi and Phlebotomus duboscqi. Ann. Trop. Med. Parasitol. 91:267–279. 10.1080/00034989761120 PubMed DOI
Dostalova A, Volf P. 2013. Leishmania development in sand flies: parasite-vector interactions overview. Parasit. Vectors 5:276. 10.1186/1756-3305-5-276 PubMed DOI PMC
Gradoni L, Maroli M, Gramiccia M, Macianti F. 1987. Leishmania infantum infection rates in Phlebotomus perniciosus fed on naturally infected dogs under antimonial treatment. Med. Vet. Entomol. 4:339–342 PubMed
Gramiccia M, Gradoni L, Orsini S. 1992. Decreased sensitivity to meglumine antimoniate (Glucantime) of Leishmania infantum isolated from dogs after several courses of drug treatment. Ann. Trop. Med. Parasitol. 86:613–620 PubMed
Robledo SM, Valencia AZ, Saravia NG. 1999. Sensitivity to Glucantime of Leishmania viannia isolated from patients prior to treatment. J. Parasitol. 85:360–366. 10.2307/3285647 PubMed DOI
Maroli M, Feliciangeli M, Bichaud L, Charrel R, Gradoni L. 2013. Phlebotomine sand flies and the spreading of leishmaniasis and other diseases of public health concern. Med. Vet. Entomol. 27:123–147. 10.1111/j.1365-2915.2012.01034.x PubMed DOI
Ait-Oudhia K, Lami P, Lesceu S, Harrat Z, Hamrioui B, Dedet JP, Pratlong F. 2009. Increase in the prevalence of canine leishmaniasis in urban Algiers (Algeria) following the 2003 earthquake. Ann. Trop. Med. Parasitol. 103:679–692. 10.1179/000349809X12554106963591 PubMed DOI
Oury B, Diabate M, Gazanion E, Barnabe C, Vergnes B, Garcia D, Pratlong F, Bastien P, Dedet JP, Sereno D. 2008. Chemosensitivity to antimony of Leishmania infantum in the region of Montpellier (South of France), p 37–42 In Dupoy-Camet J, Dei-Cas E. (ed), X European Multicolloquium of Parasitology. Medimond, Paris, France
Volf P, Volfova V. 2011. Establishment and maintenance of sand fly colonies. J. Vector Ecol. 36:S1–S9. 10.1111/j.1948-7134.2011.00106.x PubMed DOI
Myskova J, Votypka J, Volf P. 2008. Leishmania in sand flies: comparison of quantitative polymerase chain reaction with other techniques to determine the intensity of infection. J. Med. Entomol. 45:133–138. 10.1603/0022-2585(2008)45[133:LISFCO]2.0.CO;2 PubMed DOI
Sadlova J, Yeo M, Seblova V, Lewis MD, Mauricio I, Volf P, Miles MA. 2011. Visualisation of Leishmania donovani fluorescent hybrids during early stage development in the sand fly vector. PLoS One 6:e19851. 10.1371/journal.pone.0019851 PubMed DOI PMC
Vanaerschot M, Decuypere S, Berg M, Roy S, Dujardin JC. 2013. Drug-resistant microorganisms with a higher fitness—can medicines boost pathogens? Crit. Rev. Microbiol. 39:384–394. 10.3109/1040841X.2012.716818 PubMed DOI
Aït-Oudhia K, Gazanion E, Vergnes B, Oury B, Sereno D. 2011. The fitness of antimony-resistant Leishmania parasites: lessons from the field. Trends Parasitol. 27:141–142. 10.1016/j.pt.2010.12.003 PubMed DOI